Evaluation of CXCL12, CD28 and FOS gene expression in HIV-infected patients with discordance in CD4+T-Cell Levels

Document Type : Original Research

Authors
K. Kolbadi 1
E. Aliasgari 1
K. Baesi 2
1 Department of biology, East Tehran Branch, Islamic Azad University, Tehran, Iran.
2 Hepatitis and AIDS Department, Pasteur Institute of Iran, Tehran, Iran.
Abstract
Aims: Anti-Retroviral Therapy (ART) should considerably ameliorate the recovery of the immune system in HIV infected patients. In some patients a failure to satisfactorily increase CD4 counts on ART despite successful virological control did occur, named discordant immune response (DIR). The aim of this study is the evaluation of CD28, CXCL12, FOS genes in patients with DIR.



Materials & Methods: In current study, after PBMC isolation, RNA was extracted for two groups; Control group (immunologic responders) and case group (non immunologic responders). Real-time relative quantitative PCR was performed in duplicate using One Step PrimeScript™ RT-PCR Kit and data analyzed by using GraphPad prism software version 8.0.2.





Findings: The expression levels in the case group compared to the control group were measured for CD28, CXCL12, FOS. The Fold change ratio for CD28 and CXCL12 were (0.46), (0.19) respectively and in both of them, a significant decrease was observed. The Fold change ratio for FOS was (0.70) and no statistically significant was observed.

Conclusion: we showed significantly decrease in the expression of CD28 and CXCL12 genes in the case group compared to control group, but we couldn’t say, this low expression of these genes are the reason of the low count of CD4 T cells. The more investigation is necessary for it, if the suppression of these genes can impact on proliferation of CD4 T cells, in-vitro.

Keywords

1. Habeshaw J, Wilson S, Hounsell E, Oxford J: How HIV-1 lentivirus causes immune deficiency disease. Medical hypotheses 1999, 52(1):59-67.
2. Alfano M, Poli G: Cytokine and chemokine based control of HIV infection and replication. Current pharmaceutical design 2001, 7(11):993-1013.
3. Alimonti JB, Ball TB, Fowke KR: Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS. Journal of general Virology 2003, 84(7):1649-1661.
4. Galli G, Annunziato F, Mavilia C, Romagnani P, Cosmi L, Manetti R, Pupilli C, Maggi E, Romagnani S: Enhanced HIV expression during Th2‐oriented responses explained by the opposite regulatory effect of IL‐4 and IFN‐γ on fusin/CXCR4. European journal of immunology 1998, 28(10):3280-3290.
5. Benjamin R, Banerjee A, Sunder SR, Gaddam S, Valluri VL, Banerjee S: Discordance in CD4+ T-cell levels and viral loads with co-occurrence of elevated peripheral TNF-α and IL-4 in newly diagnosed HIV-TB co-infected cases. PloS one 2013, 8(8):e70250.
6. Alfano M, Crotti A, Vicenzi E, Poli G: New players in cytokine control of HIV infection. Current HIV/AIDS Reports 2008, 5(1):27-32.
7. Wang J, Roderiquez G, Oravecz T, Norcross MA: Cytokine regulation of human immunodeficiency virus type 1 entry and replication in human monocytes/macrophages through modulation of CCR5 expression. Journal of Virology 1998, 72(9):7642-7647.
8. Suzuki Y, Koyanagi Y, Tanaka Y, Murakami T, Misawa N, Maeda N, Kimura T, Shida H, Hoxie JA, O’Brien WA: Determinant in human immunodeficiency virus type 1 for efficient replication under cytokine-induced CD4+ T-helper 1 (Th1)-and Th2-type conditions. Journal of virology 1999, 73(1):316-324.
9. Hogg RS, Yip B, Chan KJ, Wood E, Craib KJ, O'Shaughnessy MV, Montaner JS: Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. Jama 2001, 286(20):2568-2577.
10. Moore DM, Hogg RS, Yip B, Wood E, Tyndall M, Braitstein P, Montaner JS: Discordant immunologic and virologic responses to highly active antiretroviral therapy are associated with increased mortality and poor adherence to therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes 2005, 40(3):288-293.
11. Kumar RS: Immunovirological discordance in HIV. MEDICINE 2012, 22.
12. Collazos J, Asensi V, Carton JA: CD4 responses in the setting or suboptimal virological responses to antiretroviral therapy: features, outcomes, and associated factors. AIDS research and human retroviruses 2009, 25(7):647-655.
13. Aiuti F, Mezzaroma I: Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART. AIDS Rev 2006, 8(2):88-97.
14. Taiwo B, Li X, Palella F, Jacobson LP, Margolick JB, Detels R, Rinaldo C, Phair J: Higher risk of AIDS or death in patients with lower CD4 cell counts after virally suppressive HAART. HIV medicine 2009, 10(10):657-660.
15. Torti C, Quiros‐Roldan E, Scudeller L, Lo Caputo S, Tomasoni L, Castelli F, Poggio A, Delle Foglie P, Chirianni A, Sighinolfi L: Characterization of viro‐immunological responses in a closely followed cohort of heavily pretreated patients: evidence from the GenPheRex Study. Hiv Medicine 2003, 4(3):263-270.
16. Gamberg J, Pardoe I, Bowmer MI, Howley C, Grant M: Lack of CD28 expression on HIV‐specific cytotoxic T lymphocytes is associated with disease progression. Immunology and cell biology 2004, 82(1):38-46.
17. Effros RB: Loss of CD28 expression on T lymphocytes: a marker of replicative senescence. Developmental & Comparative Immunology 1997, 21(6):471-478.
18. Valentin A, Lu W, Rosati M, Schneider R, Albert J, Karlsson A, Pavlakis GN: Dual effect of interleukin 4 on HIV-1 expression: implications for viral phenotypic switch and disease progression. Proceedings of the National Academy of Sciences 1998, 95(15):8886-8891.
19. Wang J, Harada A, Matsushita S, Matsumi S, Zhang Y, Shioda T, Nagai Y, Matsushima K: IL‐4 and a glucocorticoid up‐regulate CXCR4 expression on human CD4+ T lymphocytes and enhance HIV‐1 replication. Journal of Leukocyte Biology 1998, 64(5):642-649.
20. Maggi E, Mazzetti M, Ravina A, Annunziato F, De Carli M, Piccinni MP, Manetti R, Carbonari M, Pesce AM, Del Prete G: Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells. Science 1994, 265(5169):244-248.
21. Becker Y: The changes in the T helper 1 (Th1) and T helper 2 (Th2) cytokine balance during HIV-1 infection are indicative of an allergic response to viral proteins that may be reversed by Th2 cytokine inhibitors and immune response modifiers–a review and hypothesis. Virus genes 2004, 28(1):5-18.
22. Sousa A, Victorino R: Single-cell analysis of lymphokine imbalance in asymptomatic HIV-1 infection: evidence for a major alteration within the CD8+ T cell subset. Clinical and experimental immunology 1998, 112(2):294.
Pathobiology Reserach
Volume 23, Issue 5
April 2021
Pages 57-63